Completed PHASE4 INTERVENTIONAL 2-arm NCT01888744

Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist (Avanti)

The Effect of the Type of Ovarian Stimulation Protocol on PGD Results: a Prospective Randomised Trial

Sponsor: Universitair Ziekenhuis Brussel

Conditions Fertility Optimal Stimulation Protocol Reproductive Endocrinology

Interventions GnRH agonist GnRH antagonist Human chorionic gonadotropin Progesterone hP-hMG

Updated 5 times since 2017 Last updated: Jun 27, 2013 Started: Sep 30, 2010 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Fertility and Optimal Stimulation Protocol, this trial is completed. The trial is conducted by Universitair Ziekenhuis Brussel and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitair Ziekenhuis Brussel

Data source: Universitair Ziekenhuis Brussel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium